Seasoned venture investor and operator focused on fintech and enterprise SaaS, Dan Wohlgemuth brings experience scaling go-to-market teams, structuring growth rounds and advising boards. He sources and leads Series A–B investments, works with founders on commercial strategy and international expansion, and supports LP relations and capital formation. Active in seed-to-growth ecosystems, he combines operating background with investment diligence to drive exits and portfolio company operational improvements.
Seasoned venture investor and operator focused on fintech and enterprise SaaS, Dan Wohlgemuth brings experience scaling go-to-market teams, structuring growth rounds and advising boards. He sources and leads Series A–B investments, works with founders on commercial strategy and international expansion, and supports LP relations and capital formation. Active in seed-to-growth ecosystems, he combines operating background with investment diligence to drive exits and portfolio company operational improvements.
Focuses on enterprise fintech and SaaS, prioritizing founder-led teams with measurable GTM traction and clear paths to revenue scaling. Prefers Series A–B where capital accelerates go-to-market and international expansion. Combines operator-led underwriting with metrics-driven diligence, emphasizing unit economics, churn control and sales efficiency. Capital allocation favors concentrated, active positions with board or advisory engagement to de-risk execution and accelerate exits.
Focuses on enterprise fintech and SaaS, prioritizing founder-led teams with measurable GTM traction and clear paths to revenue scaling. Prefers Series A–B where capital accelerates go-to-market and international expansion. Combines operator-led underwriting with metrics-driven diligence, emphasizing unit economics, churn control and sales efficiency. Capital allocation favors concentrated, active positions with board or advisory engagement to de-risk execution and accelerate exits.
| Trades 1859 | Longs Won 1224/1859 65% | Profit Factor 12.03 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $831,904.9 |
| Average Win $205,818.97 | Best Trade (Jun 30) $15.96M | Sharpe Ratio -10.45 |
| Average Loss -$32,965.21 | Worst Trade (Mar 31) -$3.35M | Z-Score 0.22 (17.59%) |
| Commissions $0 | Avg. Trade Length 10m 3w 6d | Expectancy $124,254.71 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 16,129 | 14,516 | 12,903 | 11,290 | 9,677 | 8,065 | 6,452 | 4,839 | 3,226 | 1,613 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 19,837 | $5.05M | $6.11M | - | $1.06M | 21.07% | -1.618% |
ABBV AbbVie Inc. | 10,846 | $2.4M | $2.67M | - | $262,290.22 | 10.91% | -0.061% |
ABT Abbott Laboratories | 6,680 | $606,109 | $725,581.6 | - | $119,472.6 | 19.71% | +0.751% |
ACN Accenture plc Class A | 1,773 | $220,639 | $316,037.25 | - | $95,398.25 | 43.24% | +1.44% |
AEE Ameren Corporation | 2,165 | $244,680 | $235,660.25 | - | -$9,019.75 | -3.69% | +0.009% |
AEM Agnico Eagle Mines Limited | 2,551 | $395,738 | $456,271.86 | - | $60,533.86 | 15.3% | +0.022% |
AGG iShares Core U.S. Aggregate Bond ETF | 6,664 | $659,578 | $650,439.72 | - | -$9,138.28 | -1.39% | +0.005% |
AMD Advanced Micro Devices, Inc. | 796 | $462,404 | $384,850.09 | - | -$77,553.91 | -16.77% | +0.025% |
AMGN Amgen Inc. | 579 | $169,950.02 | $237,957.43 | - | $68,007.41 | 40.02% | +0.007% |
AMLP Alerian MLP ETF | 7,310 | $379,024 | $397,298.5 | - | $18,274.5 | 4.82% | -0.018% |
AMZN Amazon.com Inc | 10,586 | $1.96M | $2.91M | - | $943,796.08 | 48.12% | -0.015% |
AVEM Avantis Emerging Markets Equity ETF | 16,782 | $1.62M | $1.54M | - | -$77,493.66 | -4.79% | -0.434% |
B BARRICK MINING CORP Common Stock (ABR0) | 7,544 | $277,102 | $329,597.36 | - | $52,495.36 | 18.94% | +0.023% |
BA Boeing Company | 2,358 | $510,497 | $548,918.82 | - | $38,421.82 | 7.53% | -0.695% |
BAC Bank of America Corporation | 6,843 | $308,123.55 | $432,203.88 | - | $124,080.33 | 40.27% | -0.016% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 67,118 | $6.14M | $6.14M | - | -$3,157.7 | -0.05% | -0.011% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 128,358 | $9.91M | $9.72M | - | -$188,685.55 | -1.9% | +0.026% |
BMO Bank of Montreal | 2,675 | $472,729 | $485,766.62 | - | $13,037.62 | 2.76% | +0.025% |
BMY Bristol-Myers Squibb Company | 3,637 | $209,564 | $235,823.08 | - | $26,259.08 | 12.53% | +0.185% |
BRK-A Berkshire Hathaway Inc. | 1 | $748,850 | $780,086 | - | $31,236 | 4.17% | 0.0 |